Investcorp Europe Acquisition Corp I Warrant (IVCBW) Peer Comparison
$0.02
$0.00
(5.47%)
As on 18-Dec-2024 16:00EDT
Market cap
$-- Mln
Revenue (TTM)
$13 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Edit
| Investcorp Europe Acquisition Corp I Warrant (IVCBW) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | GigInternational1 (GIW) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
-- | 5,572 | 3,229 | 692 | 480 |
Revenue ($ Mln) |
13 | 440 | 2,883 | -- | -- |
Net Profit ($ Mln) |
24.24 | -1,435.01 | -118.30 | -134.20 | 3.04 |
Net Margin (%) |
183.78 | -325.91 | -4.10 | -- | -- |
RoE (%) |
43.98 | -- | -- | -40.17 | 2.34 |
Price to Earnings |
-- | -- | -- | -- | -- |
Price-To-Book |
-- | -- | 1.35 | -- | -- |
Income Statement ($ Mln)
| Investcorp Europe Acquisition Corp I Warrant (IVCBW) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | GigInternational1 (GIW) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
0.00 | 502.40 | 2,986.40 | -- | -- |
|
Cost of Revenue
|
2.41 | 378.94 | 1,886.10 | -- | -- |
|
Gross Profit
|
-2.41 | 123.46 | 1,100.30 | -- | -- |
|
Operating Expenses
|
9.31 | 114.50 | 960.60 | -- | -- |
|
Operating Profit (EBIT)
|
-9.31 | 8.96 | 139.70 | -- | -- |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
-4.41 | -245.80 | -72.70 | -- | -- |
|
Provision for Tax
|
-0.01 | 0.68 | 34.20 | -- | -- |
|
Profit after Tax (Net Income)
|
-4.41 | -246.49 | -93.50 | -- | -- |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | -- | -- | -- | -- |
Liabilities ($ Mln)
| Investcorp Europe Acquisition Corp I Warrant (IVCBW) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | GigInternational1 (GIW) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
95.07 | -596.94 | -1,152.40 | -- | -- |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
19.86 | 820.67 | 2,487.60 | -- | -- |
|
Current Liabilities
|
13.01 | 488.42 | 3,642.30 | -- | -- |
|
Total Liabilities
|
127.94 | 712.16 | 5,103.00 | -- | -- |
Assets ($ Mln)
| Investcorp Europe Acquisition Corp I Warrant (IVCBW) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | GigInternational1 (GIW) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
127.70 | 615.14 | 3,730.90 | -- | -- |
|
Current Assets
|
0.24 | 97.02 | 1,372.10 | -- | -- |
|
Total Assets
|
127.94 | 712.16 | 5,103.00 | -- | -- |
|
Total Debt*
|
4.75 | 865.55 | 3,721.30 | -- | -- |
|
Net Current Assets
|
-12.78 | -391.41 | -2,270.20 | -- | -- |
Cashflow ($ Mln)
| Investcorp Europe Acquisition Corp I Warrant (IVCBW) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | GigInternational1 (GIW) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-1.83 | 65.11 | 488.90 | -- | -- |
|
Cash Flow from Investing Activities
|
-- | -3.00 | -331.80 | -- | -- |
|
Cash from Financing Activities
|
-238.90 | -44.65 | -74.90 | -- | -- |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Investcorp Europe Acquisition Corp I Warrant (IVCBW) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | GigInternational1 (GIW) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-1.99 | 350.27 | -3.76 | -- | -- |
|
ROE (%)
|
-2.01 | 48.99 | 9.68 | -- | -- |
|
ROA (%)
|
-1.82 | -32.44 | -1.97 | -- | -- |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-- | -49.06 | -3.13 | -- | -- |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Investcorp Europe Acquisition Corp I Warrant (IVCBW) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | GigInternational1 (GIW) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-- | -0.22 | -0.03 | -- | -- |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
-107.84 | 88.52 | -31,066.67 | -- | -- |
|
EPS Growth (%)
|
-1.17 | 0.89 | -162.41 | -- | -- |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Investcorp Europe Acquisition Corp I Warrant (IVCBW) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | GigInternational1 (GIW) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-1.05 | -0.21 | -5,142.26 | -- | -- |
|
Price / Book Value
|
0.05 | -1.12 | -1.98 | -- | -- |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
1.90 | -- | 2.46 | -- | -- |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Investcorp Europe Acquisition Corp I Warrant (IVCBW) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | GigInternational1 (GIW) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.05 | -1.45 | -3.23 | -- | -- |
|
Short term debt to equity ratio
|
0.05 | -0.24 | -1.96 | -- | -- |
|
Current Ratio
|
0.02 | 0.20 | 0.38 | -- | -- |
|
Quick Ratio
|
0.02 | 0.21 | 0.39 | -- | -- |
|
Interest Coverage
|
0.92 | -1.85 | 1.38 | -- | -- |
Operating Efficiency Ratios
| Investcorp Europe Acquisition Corp I Warrant (IVCBW) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | GigInternational1 (GIW) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
-- | 1.42 | 32.85 | -- | -- |
|
Asset Turnover
|
0.00 | 0.66 | 0.63 | -- | -- |
|
Receivable days
|
-- | 2.70 | 113.66 | -- | -- |
|
Inventory Days
|
-- | -5.94 | -0.78 | -- | -- |
|
Payable days
|
197.50 | 100.43 | 48.20 | -- | -- |
|
Cash Conversion Cycle
|
-- | -103.67 | 64.67 | -- | -- |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
